ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
ANI Pharma (ANIP) Tops Q2 EPS by 1c
August 4, 2015 8:05 AM EDTANI Pharma (NASDAQ: ANIP) reported Q2 EPS of $0.55, $0.01 better than the analyst estimate of $0.54. Revenue for the quarter came in at $19.52 million versus the consensus estimate of $20.3 million.
For earnings history and earnings-related data on ANI Pharma (ANIP) click here.
... More